We are live on !
Find out more
PAP
Persistent Asset Partners Portfolio holdings
AUM
$335M
Turnover
79.96%
1-Year Est. Return
275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$66.9M
(+25%)
Cap. Flow
-$37.3M
Cap. Flow % of AUM
Cap. Flow %
-11.13%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134
Avg Time Held
Equity + Options
0.1
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$16M |
| 2 |
STMicroelectronics
STM
|
+$13.6M |
| 3 |
Amphenol
APH
|
+$10.9M |
| 4 |
Seagate
STX
|
+$7.07M |
| 5 |
Ford
F
|
+$6.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$18.4M |
| 2 |
Lumentum
LITE
|
+$14.5M |
| 3 |
AXT Inc
AXTI
|
+$13.3M |
| 4 |
Tower Semiconductor
TSEM
|
+$11.9M |
| 5 |
Micron Technology
MU
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.35% |
| 2 | Healthcare | 29.66% |
| 3 | Financials | 6.33% |
| 4 | Miscellaneous | 6.14% |
| 5 | Consumer Discretionary | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
801
Arteris
AIP
$938M
| $292 | ﹤0.01% |
+6
| New | +$192 |
2026 Q2
0 quarters
|
|
802
Chevron
CVX
$440B
| $168 | ﹤0.01% |
1
| – | – |
2026 Q1
1 quarter
|
|
803
CALL
Arbor Realty Trust
ABR
$498M
| $3 | ﹤0.01% |
335
| – | – |
2025 Q2
4 quarters
|
|
804
PUT
Apple
AAPL
$5T
| – | – |
-1
| Closed | -$23 | – |
|
805
AbbVie
ABBV
$500B
| – | – |
-6,126
| Closed | -$1.33M | – |
|
806
Adagene
ADAG
$154M
| – | – |
-35,126
| Closed | -$138K | – |
|
807
Adaptive Biotechnologies
ADPT
$3.82B
| – | – |
-6,689
| Closed | -$92.8K | – |
|
808
PUT
Ally Financial
ALLY
$11.4B
| – | – |
-94
| Closed | -$17.4K | – |
|
809
Amneal Pharmaceuticals
AMRX
$6.74B
| – | – |
-17,808
| Closed | -$221K | – |
|
810
Amerant Bancorp
AMTB
$1.12B
| – | – |
-20,874
| Closed | -$460K | – |
|
811
Adlai Nortye Group ADS
ANL
$668M
| – | – |
-33,732
| Closed | -$233K | – |
|
812
AN2 Therapeutics
ANTX
$127M
| – | – |
-38,155
| Closed | -$130K | – |
|
813
CALL
DELISTED
Apogee Therapeutics
APGE
| – | – |
-566
| Closed | -$1.93M | – |
|
814
CALL
Apollo Global Management
APO
$65.5B
| – | – |
-304
| Closed | -$75.1K | – |
|
815
PUT
Applovin
APP
$90.1B
| – | – |
-1
| Closed | -$2.02K | – |
|
816
argenx
ARGX
$51.9B
| – | – |
-253
| Closed | -$185K | – |
|
817
PUT
ARK Innovation ETF
ARKK
$6.2B
| – | – |
-49
| Closed | -$2.61K | – |
|
818
CALL
Ascendis Pharma A/S
ASND
$15.1B
| – | – |
-237
| Closed | -$27.1K | – |
|
819
CALL
Anavex Life Sciences
AVXL
$116M
| – | – |
-1,150
| Closed | -$412 | – |
|
820
Axos Financial
AX
$4.99B
| – | – |
-23,326
| Closed | -$1.98M | – |
|
|
821
AXT Inc
AXTI
$3.72B
| – | – |
-233,563
| Closed | -$13.3M | – |
|
822
Beacon Financial Corp
BBT
$2.29B
| – | – |
-9,354
| Closed | -$281K | – |
|
823
Biogen
BIIB
$34.5B
| – | – |
-1,903
| Closed | -$364K | – |
|
824
Kanzhun
BZ
$7.31B
| – | – |
-50,000
| Closed | -$670K | – |
|
825
Capricor Therapeutics
CAPR
$387M
| – | – |
-19,933
| Closed | -$604K | – |
|
Similar funds
JWM
PI
TFA
SIM
OWM
SS
BIA
TODC
Persistent Asset Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.
- Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
- Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
- Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
- Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
- Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
- Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
- Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.
Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.